HHSO100201500021C

IGF::OT::IGF

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	BARDA - ASPR / DAAPPO / BARDA DCMA
NAICS	541711
PSC	AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	COST PLUS FIXED FEE
Obligations	$38.9M
Current contract value	$38.9M
Potential contract value / ceiling	$38.9M
Start date	Sep 28, 2015
Current end date	Sep 30, 2027
Potential end date	Sep 30, 2027
Latest award activity	Jul 9, 2025
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jul 9, 2025	P00014	$0	THE PURPOSE OF THIS BILATERAL ADMINISTRATIVE MODIFICATION IS TO CHANGE THE KEY PERSONNEL AND ADD AN ALTERNATE COR. 1. CHANGE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR) AND ALTERNATIVE CONTRACTING OFFICER'S REPRESENTATIVE (COR)
Aug 8, 2024	P00013	$-440.4K	THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO DEOBLIGATE FUNDING IN THE AMOUNT OF $440,414.87 IN CANCELLING FUNDS FROM LINES 1 AND 2.
Nov 2, 2023	P00012	$0	THIS MODIFICATION COMPLETES THE TRANSFER OF THE FOLLOWING GOVERNMENT FURNISHED PROPERTY (GFP) STATED BELOW FROM CONTRACT NUMBER HHSO100201500028C TO CONTRACT NUMBER HHSO100201500021C AT NO ADDITIONAL COST TO THE CONTRACT OR TO THE U.S. GOVERNMENT.
Sep 21, 2023	P00011	$10.0M	THE PURPOSE OF THIS MODIFICATION IS TO ADD FUNDING IN THE AMOUNT OF $10,000,000.00 FOR OPTION 2 (CLIN 0003) WHICH DID NOT CORRECTLY ADD IN P00010.
Sep 12, 2023	P00010	$0	THE PURPOSE OF THIS MODIFICATION IS TO ADD FUNDING IN THE AMOUNT OF $10,000,000.00 AND EXTEND THE PERIOD OF PERFORMANCE BY 42 MONTHS FOR OPTION 2 (CLIN 0003).
Sep 23, 2022	P00009	$-54.1K	THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE $54,051.28 OF CANCELING FUNDS AS PART OF CLOSEOUT PROCEDURES. FUNDING LINE 2 IS DECREASED BY $54,051.28, FROM $2,874,188.00 TO $2,820,136.72 THE TOTAL CONTRACT CEILING AND FUNDING AMOUNT IS DECREASED
Nov 4, 2021	P00008	$0	NO-COST SUPPLEMENTAL AGREEMENT TO INCORPORATE BY EXECUTIVE ORDER 14042 - FAR DEVIATION CLAUSE 52.223-99, ENSURING ADEQUATE COVID SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS. NO OTHER CHANGES APPLY.
Aug 27, 2020	P00007	$0	NO COST EXTENSION OF CLINS 0001&0002 POP TO COMPLETE TASKS IN BASE AND OPTION 1 PERIODS RESPECTIVELY. CHANGE IN SECTION F DELIVERY. NO OTHER CHANGES APPLY.
Jun 18, 2020	P00006	$15.0M	EXERCISE OPT 2, CLIN 3 PIVOTAL CLINICAL TRIAL, CHANGE IN CX TYPE SPECIFIC TO THIS CLIN, EXTEND POP TO 9/30/2025, ADD HEALTH ECONOMIC COST MODELING UNDER CLIN 3 AS A PART OF COMMERCIALIZATION. CLIN 3 COST-SHARE USG FUNDING IN THE AMT OF $15M. CHANGE I
Apr 4, 2018	5	$3.7M	IGF::OT::IGF DEVELOPMENT OF BIODEGRADABLE TEMPORIZING MATRIX
May 28, 2016	4	$2.4M	IGF::OT::IGF DEVELOPMENT OF BIODEGRADABLE TEMPORIZING MATRIX
Apr 20, 2016	3	$0	IGF::OT::IGF DEVELOPMENT OF BIODEGRADABLE TEMPORIZING MATRIX
Mar 17, 2016	2	$0	IGF::OT::IGF
Mar 1, 2016	1	$0	IGF::OT::IGF BIODEGRADABLE TEMPORIZING MATRIX (BTM) DEVICE
Aug 20, 2015	0	$8.2M	IGF::OT::IGF

Estimated positioning window

Nov 1, 2026 – Mar 30, 2027

Recompete signal:

75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2027-09-30 (333 days from calculation): +35 points
40 historical awards in this buyer and category group: +15 points
15 recorded award transactions: +10 points
Latest award action: 2025-07-09: +0 points
Parent award identifier recorded: +0 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Check the stated set-aside against the solicitation and current certifications.
Review the award scope and buyer evidence before making a bid/no-bid decision.